Article Versions Notes

Yamamoto JK, Edison LK, Rowe-Haas DK, Takano T, Gilor C, Crews CD, Tuanyok A, Arukha AP, Shiomitsu S, Walden HDS, et al. Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses. 2023; 15(4):914. https://doi.org/10.3390/v15040914

Yamamoto, Janet K., Lekshmi K. Edison, Dawne K. Rowe-Haas, Tomomi Takano, Chen Gilor, Chiquitha D. Crews, Apichai Tuanyok, Ananta P. Arukha, Sayaka Shiomitsu, Heather D. S. Walden, and et al. 2023. "Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development" Viruses 15, no. 4: 914. https://doi.org/10.3390/v15040914

Yamamoto, J. K., Edison, L. K., Rowe-Haas, D. K., Takano, T., Gilor, C., Crews, C. D., Tuanyok, A., Arukha, A. P., Shiomitsu, S., Walden, H. D. S., Hohdatsu, T., Tompkins, S. M., Morris Jr., J. G., Sahay, B., & Kariyawasam, S. (2023). Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development. Viruses, 15(4), 914. https://doi.org/10.3390/v15040914